These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2195280)

  • 21. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
    J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards a blood-stage vaccine for malaria: are we following all the leads?
    Good MF
    Nat Rev Immunol; 2001 Nov; 1(2):117-25. PubMed ID: 11905819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New concepts in vaccine development in malaria.
    Kanoi BN; Egwang TG
    Curr Opin Infect Dis; 2007 Jun; 20(3):311-6. PubMed ID: 17471043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parasitology. Malaria vaccines: back to the future?
    Waters AP; Mota MM; van Dijk MR; Janse CJ
    Science; 2005 Jan; 307(5709):528-30. PubMed ID: 15681372
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High road, low road? Choices and challenges on the pathway to a malaria vaccine.
    Richie T
    Parasitology; 2006; 133 Suppl():S113-44. PubMed ID: 17274843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-erythrocytic malaria vaccines: towards greater efficacy.
    Hill AV
    Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contemporary vaccinology--scientific and practical aspects].
    Piotrowska-Jastrzebska J; Mikołuć B; Motkowski R
    Pol Merkur Lekarski; 2002 Jun; 12(72):526-9. PubMed ID: 12362676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
    Polhemus ME; Magill AJ; Cummings JF; Kester KE; Ockenhouse CF; Lanar DE; Dutta S; Barbosa A; Soisson L; Diggs CL; Robinson SA; Haynes JD; Stewart VA; Ware LA; Brando C; Krzych U; Bowden RA; Cohen JD; Dubois MC; Ofori-Anyinam O; De-Kock E; Ballou WR; Heppner DG
    Vaccine; 2007 May; 25(21):4203-12. PubMed ID: 17442466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax.
    Bell BA; Wood JF; Bansal R; Ragab H; Cargo J; Washington MA; Wood CL; Ware LA; Ockenhouse CF; Yadava A
    Vaccine; 2009 Feb; 27(9):1448-53. PubMed ID: 19138714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular parasitology: progress towards the development of vaccines for malaria, filariasis, and schistosomiasis.
    Cryz SJ
    Experientia; 1991 Feb; 47(2):146-51. PubMed ID: 2001716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of sporozoite vaccines for malaria.
    Chulay JD
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():61-6. PubMed ID: 2696162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Variations in human parasitic diseases: malaria and schistosomiasis (author's transl)].
    Garin JP
    Bull Soc Pathol Exot Filiales; 1981; 74(6):739-49. PubMed ID: 7343140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro cultivation of Plasmodium falciparum as a first step in the development of a malaria vaccine].
    Meuwissen JH
    Ned Tijdschr Geneeskd; 1979 Dec; 123(48):2057-60. PubMed ID: 390410
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of recombinant DNA Plasmodium falciparum sporozoite vaccine?
    Grove DI
    Lancet; 1987 Jul; 2(8552):220. PubMed ID: 2885674
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunoprophylaxis of malaria: sporozoite-induced immunity.
    Nussenzweig RS
    Adv Exp Med Biol; 1977; 93():75-87. PubMed ID: 413344
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthetic biology moving into the clinic.
    Ruder WC; Lu T; Collins JJ
    Science; 2011 Sep; 333(6047):1248-52. PubMed ID: 21885773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long struggle continues to find new weapons against an old foe--the malaria parasite.
    Marwick C
    JAMA; 1990 May 23-30; 263(20):2718. PubMed ID: 2185370
    [No Abstract]   [Full Text] [Related]  

  • 39. Sporozoite and normal salivary gland induced immunity in malaria.
    Alger NE; Harant JA; Willis LC; Jorgensen GM
    Nature; 1972 Aug; 238(5363):341. PubMed ID: 4403942
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospects and problems in the use of recombinant DNA for the production of a malaria vaccine.
    Kilejian A
    Am J Trop Med Hyg; 1980 Sep; 29(5 Suppl):1125-8. PubMed ID: 7001939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.